Welcome to homework assignment CAS 1.5 in the Cannabis for Anxiety seminar from Higher Learning LV. This assignment focuses on the therapeutic application of cannabis for anxiety and, specifically, a 2023 Australian study that examined the potential efficacy of medicinal cannabis for chronic pain, anxiety, post-traumatic stress disorder, and multiple sclerosis.
After you complete this assignment, use the button at the bottom to return to the Cannabis for Anxiety seminar master page.
A 2023 Australian study entitled "Preliminary Findings from Project Twenty21 Australia: An Observational Study of Patients Prescribed Medicinal Cannabis for Chronic Pain, Anxiety, Post-traumatic Stress Disorder, and Multiple Sclerosis" that was published in the journal Drug Science investigated the potential efficacy of cannabis for a range of conditions, including anxiety, pain, PTSD, and MS.
